0000920465-19-000010.txt : 20190109 0000920465-19-000010.hdr.sgml : 20190109 20190109212915 ACCESSION NUMBER: 0000920465-19-000010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190109 FILED AS OF DATE: 20190109 DATE AS OF CHANGE: 20190109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CARVER JENNIFER CENTRAL INDEX KEY: 0001663163 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 19519167 MAIL ADDRESS: STREET 1: 725 NEWPORT STREET CITY: DENVER STATE: CO ZIP: 80220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wf-form4_154708733697722.xml FORM 4 X0306 4 2019-01-09 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001663163 CARVER JENNIFER C/O LA JOLLA PHARMACEUTICAL COMPANY, 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 0 1 0 0 Chief Operating Officer Common Stock 2019-01-09 4 P 0 516 6.1855 A 7632 D Common Stock 2019-01-09 4 P 0 484 6.189 A 8116 D Common Stock 2019-01-09 4 P 0 1000 6.1657 A 9116 D Common Stock 2019-01-09 4 P 0 1000 6.1493 A 10116 D Common Stock 2019-01-09 4 P 0 1000 6.1565 A 11116 D Common Stock 2019-01-09 4 P 0 1000 6.1665 A 12116 D /s/ Ryan Murr, as attorney-in-fact for Jennifer A. Carver 2019-01-09